View in EDS HTML Full Text PDF Full Text

Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.

Saved in:
Bibliographic Details
Title: Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
Authors: Wickström SL; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Lövgren T; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden., Volkmar M; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Reinhold B; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Duke-Cohan JS; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Hartmann L; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Rebmann J; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Mueller A; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany., Melief J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Maas R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Ligtenberg M; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Hansson J; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden., Offringa R; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany., Seliger B; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany., Poschke I; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany., Reinherz EL; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States., Kiessling R; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
Source: Frontiers in immunology [Front Immunol] 2019 Dec 11; Vol. 10, pp. 2766. Date of Electronic Publication: 2019 Dec 11 (Print Publication: 2019).
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 31921104
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Wickström+SL%22">Wickström SL</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Lövgren+T%22">Lövgren T</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.; Department of Immunology, Genetics and Pathology, Uppsala University, Uppsala, Sweden.<br /><searchLink fieldCode="AU" term="%22Volkmar+M%22">Volkmar M</searchLink>; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Reinhold+B%22">Reinhold B</searchLink>; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Duke-Cohan+JS%22">Duke-Cohan JS</searchLink>; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Hartmann+L%22">Hartmann L</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Rebmann+J%22">Rebmann J</searchLink>; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Mueller+A%22">Mueller A</searchLink>; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.<br /><searchLink fieldCode="AU" term="%22Melief+J%22">Melief J</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Maas+R%22">Maas R</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Ligtenberg+M%22">Ligtenberg M</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Hansson+J%22">Hansson J</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.<br /><searchLink fieldCode="AU" term="%22Offringa+R%22">Offringa R</searchLink>; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Seliger+B%22">Seliger B</searchLink>; Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle, Germany.<br /><searchLink fieldCode="AU" term="%22Poschke+I%22">Poschke I</searchLink>; Division of Molecular Oncology of Gastrointestinal Tumors, German Cancer Research Center (DKFZ), Heidelberg, Germany.; DKTK Immune Monitoring Unit, German Cancer Research Center (DKFZ) and National Center for Tumor Diseases (NCT), Heidelberg, Germany.<br /><searchLink fieldCode="AU" term="%22Reinherz+EL%22">Reinherz EL</searchLink>; Laboratory of Immunobiology, Dana-Farber Cancer Institute, Boston, MA, United States.; Department of Medical Oncology, Dana-Farber Cancer Institute and Department of Medicine, Harvard Medical School, Boston, MA, United States.<br /><searchLink fieldCode="AU" term="%22Kiessling+R%22">Kiessling R</searchLink>; Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101560960%22">Frontiers in immunology</searchLink> [Front Immunol] 2019 Dec 11; Vol. 10, pp. 2766. <i>Date of Electronic Publication: </i>2019 Dec 11 (<i>Print Publication: </i>2019).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Frontiers+Research+Foundation]%22">Frontiers Research Foundation] </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>101560960 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>1664-3224 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2216643224%22">16643224 </searchLink><i>NLM ISO Abbreviation: </i>Front Immunol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=31921104
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.3389/fimmu.2019.02766
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 2766
    Titles:
      – TitleFull: Cancer Neoepitopes for Immunotherapy: Discordance Between Tumor-Infiltrating T Cell Reactivity and Tumor MHC Peptidome Display.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Wickström SL
      – PersonEntity:
          Name:
            NameFull: Lövgren T
      – PersonEntity:
          Name:
            NameFull: Volkmar M
      – PersonEntity:
          Name:
            NameFull: Reinhold B
      – PersonEntity:
          Name:
            NameFull: Duke-Cohan JS
      – PersonEntity:
          Name:
            NameFull: Hartmann L
      – PersonEntity:
          Name:
            NameFull: Rebmann J
      – PersonEntity:
          Name:
            NameFull: Mueller A
      – PersonEntity:
          Name:
            NameFull: Melief J
      – PersonEntity:
          Name:
            NameFull: Maas R
      – PersonEntity:
          Name:
            NameFull: Ligtenberg M
      – PersonEntity:
          Name:
            NameFull: Hansson J
      – PersonEntity:
          Name:
            NameFull: Offringa R
      – PersonEntity:
          Name:
            NameFull: Seliger B
      – PersonEntity:
          Name:
            NameFull: Poschke I
      – PersonEntity:
          Name:
            NameFull: Reinherz EL
      – PersonEntity:
          Name:
            NameFull: Kiessling R
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 11
              M: 12
              Text: 2019 Dec 11
              Type: published
              Y: 2019
          Identifiers:
            – Type: issn-electronic
              Value: 1664-3224
          Numbering:
            – Type: volume
              Value: 10
          Titles:
            – TitleFull: Frontiers in immunology
              Type: main
ResultId 1